SKI Market

A+| A| A-|

Indian Indices

Sensex

78,493.54 504.86
( 0.65%)

Global Indices

Nasdaq

49,467.44 867.71
(1.79%)

Dow Jones

7,146.92 84.64
(1.20%)

Hang Seng

58,837.37 -680.97
(-1.14%)

Nikkei 225

10,660.47 70.48
(0.67%)

Forex

USD-INR

93.19 -0.12
(-0.13%)

EUR-INR

109.85 -0.18
(-0.16%)

GBP-INR

126.25 -0.31
(-0.25%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Board of Directors

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532989

INE878I01022

38.5638498

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BAFNAPH

28.04

321.02

EPS(TTM)

Face Value()

Div & Yield %

4.84

E D & Wholetime Director	Shanmugam Hemalatha
ED / WTD	Vinayak Dinesh Dendukuri
Non-Exec & Non-Independent Dir	Upendar Mekala Reddy
Chairman & Independent Directo	Ravichandran Chitra
Independent Non Exe. Director	Navin Kumar
Company Sec. & Compli. Officer	A Mohanachandran
Non Executive Director	Akilapriya Chandrashekar Raju
Independent Non Exe. Director	Palamadai Krishnan Sundaresan

78,493.54 504.86 ( 0.65%)

49,467.44 867.71 (1.79%)

7,146.92 84.64 (1.20%)

58,837.37 -680.97 (-1.14%)

10,660.47 70.48 (0.67%)

93.19 -0.12 (-0.13%)

109.85 -0.18 (-0.16%)

126.25 -0.31 (-0.25%)

0.59 0.00 (-0.15%)